As of November 2024 Prelude Therapeutics has a market cap of ₹5.92 Billion. This makes Prelude Therapeutics the world's 9029th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 4th, 2024 the market cap of Prelude Therapeutics was reported to be: